Navigation Links
IsoTis Reports Status of Merger Vote
Date:10/26/2007

products for the treatment of musculoskeletal diseases and disorders. IsoTis' current orthobiologics products are bone graft substitutes that promote the regeneration of bone and are used to repair natural, trauma-related and surgically-created defects common in orthopedic procedures, including spinal fusions. IsoTis' current commercial business is highlighted by its Accell line of products, which the company believes represents the next generation in bone graft substitution.

On August 7, 2007 Integra and IsoTis announced that they have reached a definitive agreement to create a global orthobiologics leader. The combination would create a comprehensive orthobiologics portfolio, one of the largest sales organizations focused on orthobiologics in the US, and multiple cross-selling opportunities. The transaction is subject to approval of IsoTis' stockholders, as well as other closing conditions and approvals. Upon closing, IsoTis will become a wholly-owned subsidiary of Integra and Integra will be one of the largest companies in the world focused on advanced technology in orthobiologics.

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including those that refer to management's plans and expectations for, among other things, future operations, strategies, prospects, performance and financial condition and IsoTis' proposed acquisition by Integra. Words such as "strategy," "expects," "plans," "anticipates," "believes," "may," "will," "might," "could," "would," "continues," "estimates," "intends," "pursues," "projects," "goals," "targets" or the negative or other variations thereof and other words of similar meaning are intended to identify such forward-looking statements. One can also identify them by the fact that they do not relate strictly to historical or current facts. Such statements are based on the current exp
'/>"/>

SOURCE IsoTis Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based ... today announced its financial results for the three months ... $861,509 for the three months ended March 31, 2009, ... Net losses were partially offset by grant revenues ...
... PARMA, Italy, May 7 The Parma Group has ... is laying the groundwork to,acquire control of the American ... associated company in the world,s largest,pharmaceuticals market. This presence ... and new projects in the area of respiratory illnesses. ...
... a private company developing the Apollo next-generation fluidics ... F. Marion has accepted a board position to ... was former CEO of Applied Biosystems and today ... backed companies."Andre Marion brings an immense depth of ...
Cached Biology Technology:GeoVax Labs, Inc. Announces First Quarter Financial Results 2GeoVax Labs, Inc. Announces First Quarter Financial Results 3GeoVax Labs, Inc. Announces First Quarter Financial Results 4GeoVax Labs, Inc. Announces First Quarter Financial Results 5The Chiesi Group Lands in the United States 2The Chiesi Group Lands in the United States 3Andre Marion Joins Microchip Biotechnologies' Board of Directors 2
(Date:4/15/2014)... new study from the Women,s Health Initiative (WHI) shows ... symptoms. The study was published online today in ... Society., The authors analyzed the relationship between the blood ... symptoms, including hot flashes, night sweats, sleep disturbance, concentration, ... calcium and vitamin D WHI trial. , There was ...
(Date:4/15/2014)... 2020 how high sea levels will rise into the ... Florida International University scientist Rene Price. , Price is ... Coastal Everglades Long-Term Ecological Research (LTER) site, one of ... reefs to deserts, mountains to salt marshes around the ... one of the most certain consequences of climate change. ...
(Date:4/15/2014)... If an insect drew a line as it ... a tangled mess. But there,s method to that mess, ... engineering and physics, who tries to find simple physical ... https://cornell.box.com/tbeetle , It turns out the tiger beetle, ... reorientation dance as it chases its prey at blinding ...
Breaking Biology News(10 mins):Low Vitamin D may not be a culprit in menopause symptoms 2Long-term predictions for Miami sea level rise could be available relatively soon 2Photo: Tiger beetle's chase highlights mechanical law 2
... , SUNNYVALE, Calif. and ... the technology leader in intelligent video, announced that a major UK ... lane security system using Vidient,s SmartCatch video analytics suite, while a ... another such system.   , The SmartCatch system is a major ...
... COLD SPRING HARBOR, N.Y. (Mon., Feb. 1, ... long been the standard method for identifying genetic regulatory ... control regions. Sequences that are nucleosome-depleted, presumably to provide ... I. Traditional low-throughput methods use Southern blots to ...
... The search for new drug compounds is probably worse ... scientists are limited in the size of the haystacks ... impossible to screen or search through super-large libraries of ... is enormous interest in identifying synthetic molecules that bind ...
Cached Biology News:Vidient SmartCatch Protecting Exit Lanes at Major UK Airport 2Vidient SmartCatch Protecting Exit Lanes at Major UK Airport 3High-throughput analysis of gene regulation, DNA synthesis in Cold Spring Harbor Protocols 2Scripps Research scientists create new way to screen libraries of 10 million or more compounds 2Scripps Research scientists create new way to screen libraries of 10 million or more compounds 3
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
... Mouse monoclonal [SPM278] to 67kD Laminin ... lung carcinoma N592 live cells (Human). ... Not yet tested in other species. ... major glycoproteins of basement membrane, displays multiple ...
Hybridization Buffer 3.6 ml...
...
Biology Products: